Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Vacc-4x with Endocine in HIV-infected Patients
NCT01473810Phase 2Completed
- Sponsor
- Oslo University Hospital
- Start
- Nov 2011
- Primary completion
- Mar 2012
- Modality
- Peptides, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Vacc-4x in human immunodeficiency virus infection (HIV), sponsored by Oslo University Hospital. Started Nov 2011; status: completed.
02
Drugs
Vacc-4x
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01473810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01473810.